The need to transform the clinical trial landscape

An Expert View from Rajan Jethwa, chief executive of Ellipses Pharma.

The road to success in developing cancer treatments can, as the oncology sector knows only too well, be long and strewn with obstacles – many of them unavoidable.

Yet can we all say, hand on heart, that – across the sector – absolutely everything is being done to streamline a process that should ultimately be to the benefit of patients? The answer, I fear, is “no.”